Table 2: Biomarkers included in the MSD®, V-plex, 40-plex kit®.
Panel | Biomarkers included |
Vascular injury panel 2 (human) | Serum amyloid A (SAA), C-reactive protein (CRP), Vascular Cell Adhesion Molecule-1 (VCAM-1), Intercellular Adhesion Molecule-1 (ICAM-1) |
Angiogenesis panel 1 (human) | Vascular endothelial growth factor-A (VEGF-A)*, Vascular endothelial growth facto-C (VEGF-C), Vascular endothelial growth factor-D (VEGF-D), Tyrosine kinase-2 (Tie-2), Fms-like tyrosine kinase 1 (Flt-1), Placental Growth Factor (PIGF)*, Basic Fibroblast Growth Factor (bFGF) |
Chemokine panel 1 (human) | Eotaxin (CCL11), MIP-1β (CCL4), Eotaxin-3 (CCL26), TARC (CCL17), IP-10 (CXCL10), MIP-1α (CCL3), IL-8 (CXCL8)**, MCP-1 (CCL2), MDC (CCL22), MCP-4 (CCL13) |
Pro-inflammatory panel 1 (human) | Interferon (IFN)-γ, Interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, Tumor necrosis factor (TNF)-α |
Granulocyte-macrophage colony stimulating factor (GM-CSF), IL-1α, IL-5, IL-7, IL-12/IL23p40, IL-15, IL-16, IL-17A, TNF-β, VEGF |
* = Due to problems at the manufacturer PIGF and VEGF-A was not included in the analysis; ** = Quantitates high levels of IL-8 and was not used in the present analysis.